Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

U.S. and Australian group prepares new anticancer compounds

June 4, 2012

Dynamic Pharmaceuticals discovers new activators of pyruvate kinase isozyme M2

June 1, 2012

Researchers at ProMetic Life Sciences report novel phenylketone carboxylates

June 1, 2012

Viamet Pharmaceuticals discloses novel metalloenzyme inhibitors

June 1, 2012

U.S. team patents new DAP kinase 1 inhibitors and PPAR-gamma/GPR120 partial agonists

June 1, 2012

Bayer Schering Pharma divulges novel anticancer agents

June 1, 2012

New immunomodulating fusion proteins presented by MIVAC Development

June 1, 2012

Novel ddRNAi agents developed for hepatitis B

June 1, 2012

Scientists prepare new agents for urological disorders

June 1, 2012

Boehringer Ingelheim discloses novel FLAP inhibitors

May 31, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...